‘Absolute standout’ biopharma analyst Mark Schoenebaum has died
Mark Schoenebaum, one of the best known and most liked biotech analysts in the business, died over the weekend.
Umer Raffat, who was mentored by Schoenebaum and stepped into his role at Evercore ISI, put out the word on Sunday, noting:
We’ve all looked up to him as the very best equity research analyst there has ever been on Wall Street. But that was only part of who he was: he was an absolute standout individual who touched so many lives, and whose strength of character showed in his sheer humility despite his absolutely unprecedented success.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.